CRN will build on its efforts in 2019 and 2020 to establish a legal pathway for CBD and other cannabinoids in dietary supplements. We will continue our leadership role to advance federal legislation, insist FDA apply the existing dietary supplement regulatory regime to CBD supplements, and influence state-based proposals to regulate CBD at the state level modeled on federal oversight of dietary supplements generally.
See CRN's position on state regulations for CBD, CBD FAQ and published articles here.
Read our Position Paper to learn more.
